To accompany the launch of new dermal filler Kysense, aesthetic company Circa Skin will host a webinar discussing its technology and techniques.
The talk will be held on February 18 at 7pm GMT.
According to the company, Kysense is a cross linked hyaluronic acid dermal filler without lidocaine/lignocaine, manufactured by Swiss-based Kylane Laboratoires. The range includes four product choices to treat all areas of the face; Volume, Define, Precise and Extreme.
The filler has been CE approved by the British Standards Institution, the national standards body of the United Kingdom, under a class 111 classification.
The CE clinical mark study was conducted by UK aesthetic practitioner Dr Kate Goldie, as well as five international doctors, and it observed 50 participants with 110 treated injection areas.
It was observed that there was an aesthetic improvement in 95% of injected sites one month after treatment. Six and twelve months after injection, respectively, 93% and 81% of subjects still had an improvement according to the assessor.
Claire Williams, CEO of distributor Circa Skin, commented, “Kysense represents an exciting innovation and step forward in what clinical practitioners can offer their patients and we are thrilled to be launching this advancement in HA technology. In addition, we are revolutionising the business aspect for our customers, with the launch of an educational digital platform and subscription service to support our clinicians in maximising their clinical and commercial returns.”